Total Valuation
Psyrx Bio-Tech has a market cap or net worth of ₪12.28M. The enterprise value is -62.93K.
Market Cap₪12.28M
Enterprise Value-62.93K
Share Statistics
Psyrx Bio-Tech has 14,082,396 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,082,396
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Psyrx Bio-Tech’s return on equity (ROE) is -11.50 and return on invested capital (ROIC) is -289.22%.
Return on Equity (ROE)-11.50
Return on Assets (ROA)-5.06
Return on Invested Capital (ROIC)-289.22%
Return on Capital Employed (ROCE)-2.89
Revenue Per Employee0.00
Profits Per Employee-497.05K
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Psyrx Bio-Tech is ―. Psyrx Bio-Tech’s PEG ratio is 0.00533.
PE Ratio―
PS Ratio0.00
PB Ratio5.66
Price to Fair Value5.66
Price to FCF-10.58
Price to Operating Cash Flow-5.75
PEG Ratio0.00533
Income Statement
In the last 12 months, Psyrx Bio-Tech had revenue of 0.00 and earned -2.98M in profits. Earnings per share was -0.61.
Revenue0.00
Gross Profit-1.57K
Operating Income-749.74K
Pretax Income-2.98M
Net Income-2.98M
EBITDA-748.17K
Earnings Per Share (EPS)-0.61
Cash Flow
In the last 12 months, operating cash flow was -97.72K and capital expenditures 97.72K, giving a free cash flow of 0.00 billion.
Operating Cash Flow-97.72K
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Psyrx Bio-Tech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.35
52-Week Price Change-71.51%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)139.30K
Important Dates
Psyrx Bio-Tech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Psyrx Bio-Tech as a current ratio of 1.78, with Debt / Equity ratio of 0.00%
Current Ratio1.78
Quick Ratio1.78
Debt to Market Cap0.00
Net Debt to EBITDA0.63
Interest Coverage Ratio-238.90
Taxes
In the past 12 months, Psyrx Bio-Tech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Psyrx Bio-Tech EV to EBITDA ratio is -1.33, with an EV/FCF ratio of -7.16.
EV to Sales0.00
EV to EBITDA-1.33
EV to Free Cash Flow-7.16
EV to Operating Cash Flow-7.16
Balance Sheet
Psyrx Bio-Tech has ₪473.88K in cash and marketable securities with ₪0.00 in debt, giving a net cash position of ₪473.88K billion.
Cash & Marketable Securities₪473.88K
Total Debt₪0.00
Net Cash₪473.88K
Net Cash Per Share₪0.03
Tangible Book Value Per Share₪0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Psyrx Bio-Tech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast93.36%